-
Je něco špatně v tomto záznamu ?
Reanalysis of Next-Generation Sequencing Data to Detect Tandem Repeat Expansions in 1,106 Czech Probands With Neurologic Disease
A. Musilova, P. Lassuthova, A. Uhrova Meszarosova, B. Straka, J. Krejcikova, A. Berounska, M. Vlckova, Z. Musova, D. Safka Brozkova
Status neindexováno Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2015
Free Medical Journals
od 2015
Freely Accessible Science Journals
od 2015
PubMed Central
od 2015
Europe PubMed Central
od 2015
Open Access Digital Library
od 2015-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2015
- Publikační typ
- časopisecké články MeSH
BACKGROUND AND OBJECTIVES: Tandem repeats (TRs) are DNA regions of tandemly repeated nucleotide motifs. Their pathogenic expansions cause various, mainly neurologic, diseases. METHODS: We analyzed 65 TR loci using ExpansionHunter in individuals who underwent short-read whole-exome sequencing (WES) or whole-genome sequencing (WGS) for the diagnosis of a rare neurologic condition. RESULTS: Of 1,106 proband samples (1,053 WES, 53 WGS), we detected 232 TR expansions in the intermediate or pathogenic range in 18.7% (207/1,106). However, 51 TR expansions were revised as false positives (FPs) and 83 as nondisease-causing. Of the 98 disease-causing TR expansions, 5 were classified as causal hemizygous or heterozygous TR expansions associated with X-linked recessive (XLR) or autosomal dominant (AD) neurologic disorders in 5 probands (0.5%). The low incidence is due to the fact that individuals with typical clinical symptoms (spinocerebellar ataxia) were tested for TR expansion by conventional laboratory methods. Only 1 proband with clinical suspicion of spinal and bulbar muscular atrophy was fully explained by TR expansion in the AR gene, and in 4 others, we hypothesize the possible involvement of 2 different neurologic diseases. Another 82 causal hemizygous or heterozygous TR expansions associated with XLR or AD non-neurologic diseases (secondary findings) were identified in 81 probands (7.3%), of which 70 expansions in TCF4 were associated with Fuchs endothelial corneal dystrophy, a common eye disease in older patients. Finally, we detected 11 heterozygous TR expansions for XLR and autosomal recessive (AR) diseases in 11 probands who had no clinical symptoms of the associated TR disease. DISCUSSION: The unexpectedly high detection rate (18.7%) of TR expansions necessitates the filtration of FPs and nondisease-causing expansions, thereby underscoring the necessity of visual inspection of ExpansionHunter results. The study demonstrated that both WES and WGS diagnostics can benefit from TR expansion analysis. The secondary findings indicate that the previously published pathogenic ranges of TR expansions in RUNX2 and ZIC3 warrant further investigation.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25020690
- 003
- CZ-PrNML
- 005
- 20251014150356.0
- 007
- ta
- 008
- 251007s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1212/NXG.0000000000200272 $2 doi
- 035 __
- $a (PubMed)40585427
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Musilova, Alena $u Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia; and $1 https://orcid.org/0000000154933103
- 245 10
- $a Reanalysis of Next-Generation Sequencing Data to Detect Tandem Repeat Expansions in 1,106 Czech Probands With Neurologic Disease / $c A. Musilova, P. Lassuthova, A. Uhrova Meszarosova, B. Straka, J. Krejcikova, A. Berounska, M. Vlckova, Z. Musova, D. Safka Brozkova
- 520 9_
- $a BACKGROUND AND OBJECTIVES: Tandem repeats (TRs) are DNA regions of tandemly repeated nucleotide motifs. Their pathogenic expansions cause various, mainly neurologic, diseases. METHODS: We analyzed 65 TR loci using ExpansionHunter in individuals who underwent short-read whole-exome sequencing (WES) or whole-genome sequencing (WGS) for the diagnosis of a rare neurologic condition. RESULTS: Of 1,106 proband samples (1,053 WES, 53 WGS), we detected 232 TR expansions in the intermediate or pathogenic range in 18.7% (207/1,106). However, 51 TR expansions were revised as false positives (FPs) and 83 as nondisease-causing. Of the 98 disease-causing TR expansions, 5 were classified as causal hemizygous or heterozygous TR expansions associated with X-linked recessive (XLR) or autosomal dominant (AD) neurologic disorders in 5 probands (0.5%). The low incidence is due to the fact that individuals with typical clinical symptoms (spinocerebellar ataxia) were tested for TR expansion by conventional laboratory methods. Only 1 proband with clinical suspicion of spinal and bulbar muscular atrophy was fully explained by TR expansion in the AR gene, and in 4 others, we hypothesize the possible involvement of 2 different neurologic diseases. Another 82 causal hemizygous or heterozygous TR expansions associated with XLR or AD non-neurologic diseases (secondary findings) were identified in 81 probands (7.3%), of which 70 expansions in TCF4 were associated with Fuchs endothelial corneal dystrophy, a common eye disease in older patients. Finally, we detected 11 heterozygous TR expansions for XLR and autosomal recessive (AR) diseases in 11 probands who had no clinical symptoms of the associated TR disease. DISCUSSION: The unexpectedly high detection rate (18.7%) of TR expansions necessitates the filtration of FPs and nondisease-causing expansions, thereby underscoring the necessity of visual inspection of ExpansionHunter results. The study demonstrated that both WES and WGS diagnostics can benefit from TR expansion analysis. The secondary findings indicate that the previously published pathogenic ranges of TR expansions in RUNX2 and ZIC3 warrant further investigation.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lassuthova, Petra $u Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia; and $1 https://orcid.org/0000000317265868 $7 xx0110411
- 700 1_
- $a Uhrova Meszarosova, Anna $u Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia; and $1 https://orcid.org/0000000261865142 $7 xx0211953
- 700 1_
- $a Straka, Barbora $u Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia; and $1 https://orcid.org/0000000184482833
- 700 1_
- $a Krejcikova, Jana $u Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia; and $1 https://orcid.org/0009000298641852
- 700 1_
- $a Berounska, Anna $u Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia; and $1 https://orcid.org/0009000962217890
- 700 1_
- $a Vlckova, Marketa $u Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia
- 700 1_
- $a Musova, Zuzana $u Department of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia $1 https://orcid.org/0000000263288051
- 700 1_
- $a Safka Brozkova, Dana $u Neurogenetic Laboratory, Department of Paediatric Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czechia; and $1 https://orcid.org/0000000205727239
- 773 0_
- $w MED00200175 $t Neurology. Genetics $x 2376-7839 $g Roč. 11, č. 4 (2025), s. e200272
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40585427 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20251007 $b ABA008
- 991 __
- $a 20251014150403 $b ABA008
- 999 __
- $a ok $b bmc $g 2410890 $s 1258846
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 11 $c 4 $d e200272 $e 20250625 $i 2376-7839 $m Neurology. Genetics $n Neurol Genet $x MED00200175
- LZP __
- $a Pubmed-20251007